foxo4-dri senolytic 2023 2024 study Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics GET RID OF ZOMBIE CELLS

doi:10.1684/mrh.2015.0391 Moriyama Y, Yasue H, Yoshimura M, et al

Unlike NAD+ precursors that work downstream, 5-Amino-1MQ acts upstream by blocking NNMTs consumption of S-adenosyl methionine (SAM), resulting in elevated intracellular NAD+ and SAM levels without requiring direct nucleotide supplementation

Recently, a phase II multicentre, double-blind, randomized controlled trial including 338 adults with obesity were administered retatrutide (1, 2 mg starting dose increased to 4, 2 mg starting dose increased to 8, 2 mg starting dose increased to 12 mg) compared to placebo over 48 weeks [64]

Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease